Safety of colonoscopic therapy with apixaban switched from warfarin

Safety of colonoscopic therapy with apixaban switched from warfarin - Safety of colonoscopic therapy with apixaban

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019592

Enrollment

Registered

2015-11-02

Start date

2015-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal polyps

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases with warfarin to chronic atrial fibrillation, to whom we can change apixaban from warfarin

Exclusion criteria

Exclusion criteria: Cases with renal dysfunction (less than Ccr 15mL/min)

Design outcomes

Primary

Measure	Time frame
admission period and cost	—

Secondary

Measure	Time frame
rate of postoperative hemorrhage	—

Countries

Japan

Contacts

Public ContactNaohisa Yoshida

Kyoto Prefectural University of Medicine Department of Molecular Gastroenterology and Hepatology

naohisa@koto.kpu-m.ac.jp075-251-5519

Outcome results